News
See what we’ve been up to and what’s ahead.
-
FeaturedNAMeRS: An Accelerator Program to Support the FDA Roadmap to Reduce Animal Testing
-
-
-
Featured
NAMeRS: An Accelerator Program to Support the FDA Roadmap to Reduce Animal Testing
-
Featured
The NAMolution of Regulatory Science Seminar Series
-
Featured
Advancing Novel Surrogate Endpoints For Rare Disease Drug Development Workshop
-
Nabarun Dasgupta discusses street drug science at the May 2026 FDA CERSI Lecture Series
-
New Publication Advances More Meaningful, Patient-Focused Clinical Outcomes
-
Experts Debate the Role of Animal Testing at the 2026 CERSI Summit
-
Announcing NAMeRS: An Accelerator Program to Support the FDA Roadmap to Reducing Animal Testing
-
Workshop: Pediatric Drug Development Safety and New Approach Methodologies (NAMs)
-
Past Event [July 2025]: Index Date Selection for External Comparators - A Virtual Public Symposium for the Scientific Community
-
Paul Watkins interviewed by NBC News about CBD effects on the liver
-
July FDA CERSI Lecture Series features Duke Professor discussing pragmatic trials and real world data
-
UK CEiRSI announces formal partnership with Triangle CERSI
-
Virtual Imaging Trials in Medicine 2025
-
CERSI researcher Dasgupta interviewed on NPR's Morning Edition
-
CERSI PI Susan Halabi's clinical trial design leads to key finding for people with bladder cancer
-
Dr. Ehsan Samei interviewed by Radiological Society of North America
-
A Chat with Dr. Paul Watkins and Dean Kashuba of the UNC Eshelman School of Pharmacy
-
Episode 167 of Taking the Pulse: A Healthcare and Life Sciences Podcast
-
FDA gives $50M to Duke, UNC to establish world-class public health research center
-
UNC-Chapel Hill, Duke to be awarded up to $50 million from the FDA for new research center
FDA Regulatory Science News and Events
Visit the FDA CERSI website for news and events related to the Advancing Regulatory Science Initiative.